Consolidated Statement Of Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7315150

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Consolidated statement of income
Statement of income
Net sales
1,105,883,000,000 JPY
1,250,682,000,000 JPY
Cost of sales
406,600,000,000 JPY
472,843,000,000 JPY
Operating expenses
Selling, general and administrative expenses
278,107,000,000 JPY
260,242,000,000 JPY
Operating expenses
Operating profit (loss)
421,176,000,000 JPY
517,596,000,000 JPY
Gross profit (loss)
699,283,000,000 JPY
777,838,000,000 JPY
Ordinary profit (loss)
442,014,000,000 JPY
525,010,000,000 JPY
Net sales
Operating expenses
Research and development expenses
143,963,000,000 JPY
130,503,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating income
Other
21,068,000,000 JPY
6,456,000,000 JPY
Non-operating income
23,008,000,000 JPY
8,841,000,000 JPY
Extraordinary income
14,125,000,000 JPY
1,151,000,000 JPY
Non-operating expenses
2,171,000,000 JPY
1,428,000,000 JPY
Interest expenses
213,000,000 JPY
185,000,000 JPY
Non-operating expenses
Other
1,958,000,000 JPY
1,243,000,000 JPY
Extraordinary losses
13,176,000,000 JPY
7,009,000,000 JPY
Impairment losses
JPY
12,000,000 JPY
Profit (loss) before income taxes
442,962,000,000 JPY
519,152,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
13,990,000,000 JPY
1,151,000,000 JPY
Gain on sale of investment securities
101,000,000 JPY
0 JPY
Income taxes - current
115,924,000,000 JPY
160,898,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
268,000,000 JPY
0 JPY
Income taxes - deferred
2,334,000,000 JPY
-8,473,000,000 JPY
Income taxes
118,258,000,000 JPY
152,425,000,000 JPY
Profit (loss)
324,704,000,000 JPY
324,704,000,000 JPY
324,704,000,000 JPY
324,704,000,000 JPY
366,728,000,000 JPY
366,728,000,000 JPY
366,728,000,000 JPY
366,728,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.